Work

Supplementary Figure 1 from Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma

Year: 2023

Type: supplementary-materials

Abstract: Tissue slices after treatment with Gemcitabine (100 µM) or Irinotecan (30 µM) for 48 hours were fixed and embedded for immunohistochemical staining of cleaved-Caspase 3 (40X magnification, Bars = 20 µm).

DOI: 10.1158/1078-0432.22468155.v1

Authors: David Roife, Bingbing Dai, Ya'an Kang, Mayrim V. Rios Perez, Michael Pratt, Xinqun Li, Jason B. Fleming

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361931522

Cites:

Cited by:

Related to: 10